Company search
M&A activity drives momentum in biotech and healthcare
“The buying has not stopped” as excitement over weight loss drugs continues.
Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Research
Please note that this research may have been paid for by the investment company. Any opinions and ratings are not endorsed by the AIC.
Related articles
The 50 investment trusts that would have made you an ISA millionaire
Allianz Technology Trust is top performer with a return of nearly £3 million.
Related videos
Me and my trusts: Ian Cowie
Nick Gardner of the Association of Investment Companies asks journalist Ian Cowie what got him started in investing, what trusts he holds and his best advice for private investors.
Me and my trusts: Ian Cowie - what trusts do you hold and why?
Nick Gardner of the Association of Investment Companies asks journalist Ian Cowie what trusts he holds and why.
Related industry news
How healthy is your portfolio?
Over six months have passed since Cherry Reynard wrote about the biotech and healthcare sector for us in this article – The biotech bust: a case study...
2026 Trust Review: Winterflood switches to Lowland and RIT Capital in search of value
Winterflood analysts have made nine changes to their annual investment company recommendations, adding four new names and removing five as they mainta...
Obesity drugs battle prompts massive M&A wave in pharma
America’s latest skirmish over drug prices has placed a new class of weight-loss and diabetes medicines squarely in the political and financial crosshairs.
Trust Spot: Uranium fund takes breather as bids, wind-downs and buybacks keep investors on their toes
A look at October’s top risers and fallers reveals another busy month for investment companies. Best performing investment companies October’s biggest...
Investment company news brought to you by Citywire Financial Publishers Limited
and QuotedData by Marten & Co.
Data provided by Morningstar.
Company documents provided by FE fundinfo.
